Maximus, Inc. (NYSE:MMS) Insider Sells $126,159.28 in Stock

Maximus, Inc. (NYSE:MMSGet Free Report) insider Michelle F. Link sold 1,363 shares of the stock in a transaction dated Tuesday, October 1st. The shares were sold at an average price of $92.56, for a total transaction of $126,159.28. Following the transaction, the insider now directly owns 6,567 shares of the company’s stock, valued at approximately $607,841.52. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Maximus Trading Down 1.0 %

Shares of MMS traded down $0.89 during mid-day trading on Wednesday, reaching $91.86. The stock had a trading volume of 215,506 shares, compared to its average volume of 355,678. The firm has a market cap of $5.58 billion, a price-to-earnings ratio of 24.10 and a beta of 0.76. The company has a debt-to-equity ratio of 0.61, a current ratio of 1.59 and a quick ratio of 1.59. Maximus, Inc. has a 52-week low of $72.39 and a 52-week high of $93.97. The business’s fifty day moving average is $89.98 and its 200 day moving average is $86.54.

Maximus (NYSE:MMSGet Free Report) last posted its earnings results on Wednesday, August 7th. The health services provider reported $1.74 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.47 by $0.27. Maximus had a net margin of 5.59% and a return on equity of 20.91%. The firm had revenue of $1.31 billion during the quarter, compared to the consensus estimate of $1.29 billion. The company’s revenue was up 10.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.78 EPS. On average, sell-side analysts predict that Maximus, Inc. will post 6.12 EPS for the current fiscal year.

Maximus Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Saturday, August 31st. Stockholders of record on Thursday, August 15th were paid a dividend of $0.30 per share. The ex-dividend date of this dividend was Thursday, August 15th. This represents a $1.20 annualized dividend and a dividend yield of 1.31%. Maximus’s dividend payout ratio (DPR) is currently 31.50%.

Institutional Trading of Maximus

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Healthcare of Ontario Pension Plan Trust Fund increased its position in shares of Maximus by 942.9% during the second quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 323,300 shares of the health services provider’s stock worth $27,707,000 after acquiring an additional 292,300 shares in the last quarter. Sanctuary Advisors LLC purchased a new position in Maximus during the second quarter valued at $216,000. New Century Financial Group LLC lifted its stake in Maximus by 2.1% during the 2nd quarter. New Century Financial Group LLC now owns 13,003 shares of the health services provider’s stock valued at $1,114,000 after acquiring an additional 264 shares during the period. Ariadne Wealth Management LP purchased a new stake in shares of Maximus in the second quarter worth $90,000. Finally, Creative Planning lifted its position in Maximus by 17.7% during the second quarter. Creative Planning now owns 15,205 shares of the health services provider’s stock valued at $1,303,000 after purchasing an additional 2,292 shares during the last quarter. Institutional investors and hedge funds own 97.21% of the company’s stock.

About Maximus

(Get Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Featured Articles

Insider Buying and Selling by Quarter for Maximus (NYSE:MMS)

Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.